亚洲 · 区域市场 · Business Standard
Sebi warns Dabur India over delay in disclosing USFDA warning letter
The market regulator has cautioned Dabur India over delayed disclosure of a USFDA warning letter, saying repeated violations could attract enforcement action under Sebi rules.
在 Business Standard 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.business-standard.com)
